YAP1 immunoreactivity was found in the nuclei of tumor cells in 64.8% of ccRCC patients, whereas only 24.1% of tumors revealed cytoplasmic YAP1 expression. The gene discussed is YAP1; the disease is nonpapillary renal cell carcinoma.